ficusin has been researched along with Carcinoma, Epidermoid in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibbotson, S | 1 |
| Abeni, D; Didona, B; Paradisi, A; Russo, N; Sobrino, L; Tabolli, S | 1 |
| Ibuki, Y; Toyooka, T | 1 |
| Bäck, B; Cerroni, L; Kerl, H; Kreimer-Erlacher, H; Seidl, H; Wolf, P | 1 |
| Bäck, B; Kerl, H; Kreimer-Erlacher, H; Seidl, H; Soyer, HP; Wolf, P | 1 |
| Christensen, LA; Conti, CJ; Fischer, SM; Vasquez, KM | 1 |
| Lim, JL; Stern, RS | 1 |
| Liebman, EJ; Stern, RS; Väkevä, L | 1 |
| Fergin, P; Gill, D; Kelly, J | 1 |
| Katz, KA; Marcil, I; Stern, RS | 1 |
| Bagheri, S; Nichols, K; Stern, RS | 1 |
1 review(s) available for ficusin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Drug and chemical induced photosensitivity from a clinical perspective.
Topics: Carcinoma, Squamous Cell; Erythema; Ficusin; Humans; Photosensitivity Disorders; Photosensitizing Agents; Psoriasis; Skin Neoplasms; Sunscreening Agents; Ultraviolet Rays | 2018 |
1 trial(s) available for ficusin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
Topics: Administration, Oral; Adult; Analysis of Variance; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Ficusin; Follow-Up Studies; Humans; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Psoriasis; Risk Factors; Skin Neoplasms; Ultraviolet Rays | 1998 |
9 other study(ies) available for ficusin and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Female; Ficusin; Humans; Incidence; Logistic Models; Male; Melanoma; Middle Aged; Multivariate Analysis; Photosensitizing Agents; Risk; Risk Factors; Skin Neoplasms; Ultraviolet Therapy; Vitiligo | 2014 |
Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair.
Topics: Apoptosis; Butyrates; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Repair; Drug Synergism; Enzyme Inhibitors; Ficusin; Histone Deacetylase Inhibitors; Humans; Melanoma; Photosensitizing Agents; PUVA Therapy; Skin Neoplasms | 2009 |
High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
Topics: Adult; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; DNA Fingerprinting; DNA Mutational Analysis; Female; Ficusin; Humans; Male; Middle Aged; Mutation; Photosensitizing Agents; Polymorphism, Single-Stranded Conformational; Psoriasis; PUVA Therapy; Skin Neoplasms; Tumor Suppressor Protein p14ARF | 2003 |
The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
Topics: Adult; Carcinoma, Squamous Cell; Female; Ficusin; Genes, p53; Genes, ras; Humans; Keratosis; Male; Middle Aged; Mutation, Missense; Neoplasms, Radiation-Induced; Psoriasis; PUVA Therapy; Radiation-Sensitizing Agents; Risk Factors; Skin Neoplasms; Ultraviolet Rays | 2004 |
Mutation frequencies in murine keratinocytes as a function of carcinogenic status.
Topics: Animals; Base Sequence; Carcinoma; Carcinoma, Squamous Cell; Cells, Cultured; Cross-Linking Reagents; DNA Damage; Ficusin; Gene Frequency; Genes, Suppressor; Keratinocytes; Mice; Mice, Inbred SENCAR; Molecular Sequence Data; Mutation; Papilloma; Plasmids; Reference Values; RNA, Transfer | 2004 |
High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Environmental Exposure; Female; Ficusin; Follow-Up Studies; Humans; Incidence; Male; Photosensitizing Agents; Psoriasis; Risk Factors; Skin Neoplasms; Ultraviolet Rays | 2005 |
Bullous lesions in Bazex syndrome and successful treatment with oral psoralen phototherapy.
Topics: Acrodermatitis; Administration, Oral; Biopsy; Carcinoma, Squamous Cell; Ficusin; Head and Neck Neoplasms; Humans; Keratosis; Male; Middle Aged; Paraneoplastic Syndromes; Photosensitizing Agents; PUVA Therapy | 2001 |
Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Female; Ficusin; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Neoplasms, Second Primary; Photosensitizing Agents; Psoriasis; Risk Factors; Skin Neoplasms; Survival Analysis; Ultraviolet Rays | 2002 |
The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
Topics: Adult; Age Distribution; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Ficusin; Genital Neoplasms, Male; Genitalia, Male; Humans; Incidence; Male; Middle Aged; Probability; Prognosis; Prospective Studies; Psoriasis; PUVA Therapy; Risk Factors; Skin Neoplasms | 2002 |